Bioreactor Group, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
J Tissue Eng Regen Med. 2019 Jul;13(7):1203-1216. doi: 10.1002/term.2871. Epub 2019 May 29.
For clinical and/or pharmaceutical use of human-induced pluripotent stem cells (hiPSCs), large cell quantities of high quality are demanded. Therefore, we combined the expansion of hiPSCs in closed, perfusion-based 3D bioreactors with noninvasive online monitoring of oxygen as culture control mechanism. Bioreactors with a cell compartment volume of 3 or 17 ml were inoculated with either 10 × 10 or 50 × 10 cells, and cells were expanded over 15 days with online oxygen and offline glucose and lactate measurements being performed. The CellTiter-Blue® Assay was performed at the end of the bioreactor experiments for indirect cell quantification. Model simulations enabled an estimation of cell numbers based on kinetic equations and experimental data during the 15-day bioreactor cultures. Calculated oxygen uptake rates (OUR), glucose consumption rates (GCR), and lactate production rates (LPR) revealed a highly significant correlation (p < 0.0001). Oxygen consumption, which was measured at the beginning and the end of the experiment, showed a strong culture growth in line with the OUR and GCR data. Furthermore, the yield coefficient of lactate from glucose and the OUR to GCR ratio revealed a shift from nonoxidative to oxidative metabolism. The presented results indicate that oxygen is equally as applicable as parameter for hiPSC expansion as glucose while providing an accurate real-time impression of hiPSC culture development. Additionally, oxygen measurements inform about the metabolic state of the cells. Thus, the use of oxygen online monitoring for culture control facilitates the translation of hiPSC use to the clinical setting.
对于临床和/或药物应用中的人类诱导多能干细胞(hiPSCs),需要大量高质量的细胞。因此,我们将 hiPSCs 在封闭、基于灌注的 3D 生物反应器中的扩增与作为培养控制机制的非侵入性在线氧监测相结合。细胞腔体积为 3 或 17ml 的生物反应器分别接种了 10×10 或 50×10 个细胞,并在 15 天内进行了在线氧和离线葡萄糖和乳酸测量的扩增。在生物反应器实验结束时,使用 CellTiter-Blue® Assay 进行间接细胞定量。模型模拟根据动力学方程和 15 天生物反应器培养期间的实验数据,对细胞数量进行了估计。计算的氧摄取率(OUR)、葡萄糖消耗率(GCR)和乳酸生成率(LPR)显示出高度显著的相关性(p<0.0001)。在实验开始和结束时测量的耗氧量与 OUR 和 GCR 数据一致,表明培养物生长强劲。此外,从葡萄糖生成的乳酸产率和 OUR 与 GCR 之比表明代谢从非氧化向氧化转变。所呈现的结果表明,氧与葡萄糖一样适用于 hiPSC 扩增作为参数,同时为 hiPSC 培养发展提供了准确的实时印象。此外,氧测量可以了解细胞的代谢状态。因此,在线监测氧用于培养控制有助于将 hiPSC 的应用转化为临床环境。